BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuwana M, Okazaki Y, Kajihara M, Kaburaki J, Miyazaki H, Kawakami Y, Ikeda Y. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia. Arthritis Rheum 2002;46:2148-59. [PMID: 12209520 DOI: 10.1002/art.10420] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Uchida M, Ooka S, Goto Y, Suzuki K, Fujimoto H, Ishimori K, Matsushita H, Takakuwa Y, Kawahata K. Anti-IL-10 antibody in systemic lupus erythematosus. Open Access Rheumatol 2019;11:61-5. [PMID: 30988645 DOI: 10.2147/OARRR.S191953] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
2 Galanopoulos N, Christoforidou A, Bezirgiannidou Z. Lupus thrombocytopenia: pathogenesis and therapeutic implications. Mediterr J Rheumatol 2017;28:20-6. [PMID: 32185250 DOI: 10.31138/mjr.28.1.20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
3 Abadi U, Yarchovsky-dolberg O, Ellis MH. Immune Thrombocytopenia: Recent Progress in Pathophysiology and Treatment. Clin Appl Thromb Hemost 2015;21:397-404. [DOI: 10.1177/1076029614526639] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
4 Arnold DM, Vrbensky JR, Karim N, Smith JW, Liu Y, Ivetic N, Kelton JG, Nazy I. The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia. Br J Haematol 2017;178:302-7. [DOI: 10.1111/bjh.14664] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
5 Suyama T, Hagihara M, Kubota N, Osamura Y, Shinka Y, Miyao N. Acquired amegakaryocytic thrombocytopenia after durvalumab administration. J Clin Exp Hematop 2021;61:53-7. [PMID: 33431742 DOI: 10.3960/jslrt.20047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hanata N, Shoda H, Kono M, Komai T, Natsumoto B, Tsuchida Y, Tsuchiya H, Nagafuchi Y, Taoka K, Kurokawa M, Fujio K. Immature platelet levels correlate with disease activity and predict treatment response of thrombocytopenia in lupus patients. Lupus 2021;:9612033211034233. [PMID: 34304626 DOI: 10.1177/09612033211034233] [Reference Citation Analysis]
7 Glaspy J. Disorders of Blood Cell Production in Clinical Oncology. Abeloff's Clinical Oncology. Elsevier; 2008. pp. 677-92. [DOI: 10.1016/b978-0-443-06694-8.50049-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
8 Michel M, Lega JC, Terriou L. [Secondary ITP in adults]. Rev Med Interne 2021;42:50-7. [PMID: 33139079 DOI: 10.1016/j.revmed.2020.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Velo-garcía A, Castro SG, Isenberg DA. The diagnosis and management of the haematologic manifestations of lupus. Journal of Autoimmunity 2016;74:139-60. [DOI: 10.1016/j.jaut.2016.07.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
10 Hara A, Furuichi K, Higuchi M, Iwata Y, Sakai N, Kaneko S, Wada T. Autoantibodies to erythropoietin receptor in patients with immune-mediated diseases: relationship to anaemia with erythroid hypoplasia. Br J Haematol 2013;160:244-50. [PMID: 23151030 DOI: 10.1111/bjh.12105] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
11 Silverman E, Eddy A. SYSTEMIC LUPUS ERYTHEMATOSUS. Textbook of Pediatric Rheumatology. Elsevier; 2011. pp. 315-43. [DOI: 10.1016/b978-1-4160-6581-4.10021-4] [Cited by in Crossref: 18] [Article Influence: 1.6] [Reference Citation Analysis]
12 Gupta L, Gupta V, Pani KC, Mittal N, Agarwal V. Successful use of azathioprine in glucocorticoid refractory immune amegakaryocytic thrombocytopenia of lupus. Reumatol Clin (Engl Ed) 2020;16:249-50. [PMID: 29678667 DOI: 10.1016/j.reuma.2018.03.005] [Reference Citation Analysis]
13 Son B, Park HS, Han HS, Kim HK, Baek SW, Yang Y, Lee KH, Kwon J. A Case of Acquired Amegakaryocytic Thrombocytopenia with Anti-c-mpl Autoantibody: Comparison with Idiopathic Thrombocytopenic Purpura. Acta Haematol 2019;142:239-43. [PMID: 31132762 DOI: 10.1159/000499523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Roeser A, Moulis G, Ebbo M, Terriou L, Poullot E, Lioger B, Chilles M, Labussière-Wallet H, Mausservey C, Pha M, Puyade M, Cheze S, Limal N, Michel M, Godeau B, Mahévas M. Characteristics, management and outcome of acquired amegakaryocytic thrombocytopenia. Br J Haematol 2022. [PMID: 35538740 DOI: 10.1111/bjh.18235] [Reference Citation Analysis]
15 Fujimi A, Kamihara Y, Hashimoto A, Kanisawa Y, Nakajima C, Hayasaka N, Yamada S, Okuda T, Minami S, Ono K, Iyama S, Kato J. Identification of anti-thrombopoietin receptor antibody in prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation treated successfully with eltrombopag. Int J Hematol 2015;102:471-6. [DOI: 10.1007/s12185-015-1806-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
16 Hara A, Furuichi K, Yamahana J, Yasuda H, Iwata Y, Sakai N, Shimizu M, Kaneko S, Wada T. Effect of Autoantibodies to Erythropoietin Receptor in Systemic Lupus Erythematosus with Biopsy-proven Lupus Nephritis. J Rheumatol 2016;43:1328-34. [PMID: 27134248 DOI: 10.3899/jrheum.151430] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
17 Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113:6511-6521. [PMID: 19395674 DOI: 10.1182/blood-2009-01-129155] [Cited by in Crossref: 444] [Cited by in F6Publishing: 384] [Article Influence: 34.2] [Reference Citation Analysis]
18 Zhang W, Dang S, Wang J, Nardi MA, Zan H, Casali P, Li Z. Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66. Autoimmunity 2010;43:682-9. [PMID: 20828249 DOI: 10.3109/08916934.2010.506207] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
19 Olsson B, Ridell B, Jernås M, Wadenvik H. Increased number of B-cells in the red pulp of the spleen in ITP. Ann Hematol 2012;91:271-7. [DOI: 10.1007/s00277-011-1292-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
20 Nazy I, Kelton JG, Moore JC, Clare R, Horsewood P, Smith JW, Ivetic N, D'souza V, Li N, Arnold DM. Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia. Br J Haematol 2018;181:234-41. [DOI: 10.1111/bjh.15165] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
21 Katsumata Y, Suzuki T, Kuwana M, Hattori Y, Akizuki S, Sugiura H, Matsuoka Y. Anti-c-Mpl (thrombopoietin receptor) autoantibody-induced amegakaryocytic thrombocytopenia in a patient with systemic sclerosis. Arthritis Rheum 2003;48:1647-51. [PMID: 12794833 DOI: 10.1002/art.10965] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
22 Karpouzas GA. Hematologic and Lymphoid Abnormalities in SLE. Dubois' Lupus Erythematosus and Related Syndromes. Elsevier; 2013. pp. 426-37. [DOI: 10.1016/b978-1-4377-1893-5.00034-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
23 Nishino S, Kodaka T, Sawada Y, Goka T, Gotoh Y, Tsunemine H, Takahashi T. Marked rebound thrombocytosis in response to glucocorticoids in a patient with acquired amegakaryocytic thrombocytopenia. J Clin Exp Hematop 2018;58:166-70. [PMID: 30416171 DOI: 10.3960/jslrt.18016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Nakamura M, Tanaka Y, Satoh T, Kawai M, Hirakata M, Kaburaki J, Kawakami Y, Ikeda Y, Kuwana M. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism. Rheumatology 2006;45:150-6. [DOI: 10.1093/rheumatology/kei118] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
25 Fukushima T, Dong L, Sakai T, Sawaki T, Miki M, Tanaka M, Masaki Y, Hirose Y, Kuwana M, Umehara H. Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus. Lupus 2008;17:210-4. [PMID: 18372362 DOI: 10.1177/0961203307086032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
26 Kuwana M, Okano Y, Pandey JP, Silver RM, Fertig N, Medsger TA Jr. Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis. Arthritis Rheum 2005;52:2425-32. [PMID: 16052583 DOI: 10.1002/art.21232] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 4.1] [Reference Citation Analysis]
27 Ichikawa T, Shimojima Y, Otuki T, Ueno KI, Kishida D, Sekijima Y. Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine. Intern Med. 2019;58:3473-3478. [PMID: 31391399 DOI: 10.2169/internalmedicine.2929-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Jing F, Zhang X, Meng F, Liu X, Shi Y, Qin P, Wang L, Zhou H, Hou Y, Song Q, Peng J, Hou M. Anti-c-Mpl antibodies in immune thrombocytopenia suppress thrombopoiesis and decrease response to rhTPO. Thrombosis Research 2018;170:200-6. [DOI: 10.1016/j.thromres.2018.08.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
29 Kajihara M, Okazaki Y, Kato S, Ishii H, Kawakami Y, Ikeda Y, Kuwana M. Evaluation of platelet kinetics in patients with liver cirrhosis: similarity to idiopathic thrombocytopenic purpura. J Gastroenterol Hepatol 2007;22:112-8. [PMID: 17201890 DOI: 10.1111/j.1440-1746.2006.04359.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
30 Ichimata S, Kobayashi M, Honda K, Shibata S, Matsumoto A, Kanno H. Acquired amegakaryocytic thrombocytopenia previously diagnosed as idiopathic thrombocytopenic purpura in a patient with hepatitis C virus infection. World J Gastroenterol 2017; 23(35): 6540-6545 [PMID: 29085203 DOI: 10.3748/wjg.v23.i35.6540] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
31 Consolini R, Legitimo A, Caparello MC. The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis. Front Pediatr 2016;4:102. [PMID: 27807534 DOI: 10.3389/fped.2016.00102] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
32 Wang JY, Ye S, Zhong H. The role of bone marrow microenvironment in platelet production and their implications for the treatment of thrombocytopenic diseases. Hematology 2017;22:630-9. [PMID: 28569613 DOI: 10.1080/10245332.2017.1333274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
33 Fabien N, Monier JC. [Antireceptor and antichannel autoantibodies]. Pathol Biol (Paris) 2006;54:309-16. [PMID: 16848005 DOI: 10.1016/j.patbio.2005.12.003] [Reference Citation Analysis]
34 Arkfeld DG, Weitz IC. Immune thrombocytopenia in patients with connective tissue disorders and the antiphospholipid antibody syndrome. Hematol Oncol Clin North Am. 2009;23:1239-1249. [PMID: 19932431 DOI: 10.1016/j.hoc.2009.08.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
35 Hepburn AL, Narat S, Mason JC. The management of peripheral blood cytopenias in systemic lupus erythematosus. Rheumatology 2010;49:2243-54. [DOI: 10.1093/rheumatology/keq269] [Cited by in Crossref: 85] [Cited by in F6Publishing: 63] [Article Influence: 7.1] [Reference Citation Analysis]
36 Ziakas PD, Routsias JG, Giannouli S, Tasidou A, Tzioufas AG, Voulgarelis M. Suspects in the tale of lupus-associated thrombocytopenia. Clin Exp Immunol 2006;145:71-80. [PMID: 16792676 DOI: 10.1111/j.1365-2249.2006.03122.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
37 Zhao L, Xu D, Qiao L, Zhang X. Bone Marrow Megakaryocytes May Predict Therapeutic Response of Severe Thrombocytopenia in Patients with Systemic Lupus Erythematosus. J Rheumatol 2016;43:1038-44. [DOI: 10.3899/jrheum.150829] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
38 Kuwana M, Kaburaki J, Okazaki Y, Miyazaki H, Ikeda Y. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus. Rheumatology 2006;45:851-4. [DOI: 10.1093/rheumatology/kel010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
39 Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009;46:S2-S14. [PMID: 19245930 DOI: 10.1053/j.seminhematol.2008.12.005] [Cited by in Crossref: 117] [Cited by in F6Publishing: 100] [Article Influence: 9.0] [Reference Citation Analysis]
40 Nugent D, McMillan R, Nichol JL, Slichter SJ. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. Br J Haematol 2009;146:585-96. [PMID: 19466980 DOI: 10.1111/j.1365-2141.2009.07717.x] [Cited by in Crossref: 153] [Cited by in F6Publishing: 118] [Article Influence: 11.8] [Reference Citation Analysis]
41 Le Clef Q, Menter T, Tzankov A. Our approach to bone marrow biopsies in cytopenia. Pathol Res Pract 2019;215:152447. [PMID: 31101575 DOI: 10.1016/j.prp.2019.152447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Her MY, Kim TH, Chang HK, Lee WS, Yoo DH. Successful treatment of acquired amegakaryocytic thrombocytopenia with cyclosporine in adult onset Still's disease. Rheumatol Int 2007;27:295-8. [PMID: 16957888 DOI: 10.1007/s00296-006-0202-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
43 Audia S, Lorcerie B, Godeau B, Bonnotte B. [Pathophysiology of immune thrombocytopenia]. Rev Med Interne 2011;32:350-7. [PMID: 20557985 DOI: 10.1016/j.revmed.2009.05.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
44 Cines DB, Cuker A, Semple JW. Pathogenesis of immune thrombocytopenia. La Presse Médicale 2014;43:e49-59. [DOI: 10.1016/j.lpm.2014.01.010] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]